Innovation Medical(SZ:002173) Sou Hu Cai Jing·2026-02-24 01:28Core Viewpoint - Innovation Medical (002173) shows a mixed financial performance with a slight decline in revenue but significant growth in net profit for the first three quarters of 2025 [3]. Group 1: Stock Performance - As of February 13, 2026, Innovation Medical's stock closed at 29.46 yuan, up 1.62%, with a turnover rate of 10.8% and a trading volume of 449,500 hands, resulting in a transaction amount of 1.319 billion yuan [1]. - On February 13, the net inflow of main funds was 85.61 million yuan, accounting for 6.49% of the total transaction amount, while retail investors saw a net outflow of 111 million yuan, representing 8.45% of the total transaction amount [1]. Group 2: Financing and Margin Trading - In the financing and margin trading data, on the same day, the financing buy amounted to 111 million yuan, while financing repayment was 123 million yuan, resulting in a net repayment of 12.14 million yuan [2]. - The margin trading data indicates no shares were sold or repaid, with a remaining margin of 13,700 shares and a margin balance of 403,600 yuan [2]. Group 3: Financial Performance - For the first three quarters of 2025, Innovation Medical reported a main revenue of 597 million yuan, a year-on-year decrease of 2.11%, while the net profit attributable to shareholders was 4.7244 million yuan, showing a year-on-year increase of 116.97% [3]. - The third quarter alone saw a main revenue of 196 million yuan, down 3.16% year-on-year, but the net profit attributable to shareholders surged by 236.15% to 16.0857 million yuan [3]. - The company reported a debt ratio of 17.84%, investment income of 29.5055 million yuan, financial expenses of 605,500 yuan, and a gross profit margin of 10.08% [3].